1mg, best e pharmacy in India




Pegaptanib is used in the treatment of wet form of age-related macular degeneration (growth of abnormal blood vessels in eye leading to gradual loss of vision), diabetic macular edema (accumulation of fluid in eye of diabetic patients) and macular oedema due to retinal vein occlusion

How it works

Pegaptanib is a monoclonal antibody. It blocks the formation of abnormal blood vessels.

Common side effects

Foreign body sensation in eyes, Blurred vision, Increased intraocular pressure, Punctate keratitis, Visual disturbance, Eye pain, Conjunctival hemorrhage, Burning sensation in eye, Corneal edema, Eye inflammation, Increased blood pressure, Stinging in the eyes, Eye floaters, Eye itching, Visual impairment, Eye discharge, Cataract

Available Medicine

  • ₹44571
    Pfizer Ltd
    1 variant(s)

Expert advice

  • Consult your ophthalmologist immediately if the eye becomes red, sensitive to light, painful or develops a change in vision.
  • Patients should not drive or use machines immediately after receiving pegaptanib intravitreal injection which may influence the driving ability.
  • Before taking pegaptanib, inform you doctor if you are pregnant, planning a pregnancy or breast-feeding.

Frequently asked questions



What is pegaptanib sodium?
Pegaptanib injection belongs to a class of medications called vascular endothelial growth factor (VEGF) antagonists. Pegaptanib is mainly used for the treatment of exudative (wet) neovascular age-related macular degeneration (AMD, a disease of the eye that affects vision).

Content on this page was last updated on 15 February, 2017, by Dr. Varun Gupta (MD Pharmacology)